Pharmaceutical News

RSS

AJMC addresses role of community pharmacies in boosting adult vaccination rates

A recent publication from The American Journal of Managed Care, the leading peer-reviewed journal dedicated to issues in managed care, addresses the role of community pharmacies in boosting adult vaccination rates in the United States.

17 Aug 2018

New statewide program in North Dakota aims to stem opioid misuse

Preliminary estimates released by the U.S. Centers for Disease Control and Prevention show a nearly 7 percent increase in drug overdoses in 2017, with more than 72,000 deaths. Of the total deaths, almost 68 percent of them were tied to opioid use. A new statewide program in North Dakota called ONE Rx aims to stem opioid misuse by increasing awareness when patients first fill an opioid prescription.

17 Aug 2018

ACA's Medicaid expansion associated with increase in prescriptions for opioid use disorder treatment

Medicaid expansion under the Affordable Care Act (ACA) was associated with an overall increase in people filling prescriptions for buprenorphine with naloxone, which is a treatment for opioid use disorder, as well as an increase in people filling prescriptions for opioid pain relievers (OPRs) paid for by Medicaid in a data analysis from five states.

17 Aug 2018

Ology Bioservices wins $8.4 million worth agreement to manufacture anti-Ebola monoclonal antibody

Ology Bioservices, Inc., a biologics contract development and manufacturing organization, announced today that it was awarded an Other Transaction Agreement to support the Joint Project Manager Medical Countermeasure Systems, a component of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense for advanced biologics manufacturing services—specifically, to manufacture an anti-Ebola monoclonal antibody.

17 Aug 2018

OHSU professor conducts clinical trial with artificial pancreas using Xeris' liquid glucagon

Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that Jessica Castle, M.D., an associate professor of medicine in the OHSU School of Medicine and OHSU Harold Schnitzer Diabetes Health Center in Portland, Oregon, is conducting a clinical trial with a dual-hormone artificial pancreas using Xeris' ready-to-use liquid glucagon to evaluate a new closed-loop algorithm.

17 Aug 2018

Biomarker predicts kidney cancer risk years before diagnosis

Scientists have identified a blood biomarker that could be used to predict the onset of renal cell carcinoma (RCC) years before the disease is diagnosed.

17 Aug 2018

Hologic’s Cynosure division partners with Porter Instrument to distribute nitrous oxide and oxygen system

Hologic, Inc. today announced completion of an agreement between its Cynosure division and Porter Instrument, a business unit of Parker Hannifin Corporation, for distribution rights in the United States and Canada to Porter Instrument’s nitrous oxide and oxygen system, Nitronox.

From Hologic, Inc. 17 Aug 2018

Statins may improve conditions of people with rare lung disease

In the first study of its kind, researchers have found that cholesterol-lowering statins may improve the conditions of people with a rare lung disease called autoimmune pulmonary alveolar proteinosis. The research also suggested that two new tests could help diagnose the condition.

17 Aug 2018

AGA urges policymakers and stakeholders to improve affordability of drugs

Increasing out-of-pocket expenses can limit access for patients, putting them at risk. Improving affordability requires a multi-faceted approach from across the health care system, including health insurers, drug and biologic manufacturers, and pharmacy benefit managers.

17 Aug 2018

FDA grants approval for first generic version of epinephrine auto-injector

The U.S. Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds.

16 Aug 2018

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

Vertex Pharmaceuticals Incorporated today announced the U.S. Food and Drug Administration approved KALYDECO® (ivacaftor) to include use in children with cystic fibrosis ages 12 to <24 months who have at least one mutation in their cystic fibrosis transmembrane conductance regulator gene that is responsive to KALYDECO based on clinical and/or in vitro assay data.

16 Aug 2018

Sun Pharma receives U.S. FDA approval for CEQUA to treat patients with dry eye disease

Sun Pharmaceutical Industries Ltd. today announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration. CEQUA is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).

16 Aug 2018

Two thyroid medications recalled by FDA

The United States Food and Drug Administration (FDA) have announced the recall of two thyroid medications due to issues with their ingredients.

16 Aug 2018

New polyclonal immunotherapy successfully neutralizes Ebola virus

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided "100% protection against a lethal dose of the Ebola virus" in a recent animal study published in The Journal of Infectious Diseases.

15 Aug 2018

Powerful psychedelic compound can model near-death experiences in the brain

A powerful psychedelic compound found in ayahuasca can model near-death experiences in the brain, a study has found.

15 Aug 2018

Johns Hopkins expert panel develops first set of operation-specific opioid prescribing guidelines

A Johns Hopkins expert panel of health care providers and patients have announced what is, to their knowledge, the nation's first set of operation-specific opioid prescribing guidelines.

14 Aug 2018

New digital pharmacy aims to help people living with chronic care conditions

Thirty jobs are to be created through a new £1.5m ‘Tele-Pharmacy’opening in Liverpool, aimed at helping people living with chronic care conditions to manage their medicinal needs through the UK’s only artificial intelligent mobile app ‘Now Patient’.

From Infohealth Ltd 14 Aug 2018

NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease

The Departments of Emergency Medicine and Hematology at the Icahn School of Medicine at Mount Sinai have been awarded a $4 million grant from the National Institutes of Health toward further study of inhaled corticosteroids to treat sickle cell disease in individuals who do not have asthma.

14 Aug 2018

Using peripheral nerve blocks to treat facial pain may produce long-term pain relief

A new study has shown that use of peripheral nerve blocks in the treatment of Trigeminal Neuralgia may produce long-term pain relief.

14 Aug 2018

New strategy accelerates, automates process of prototype molecule optimization

The search for new medicinal molecules with predetermined properties is a rather complex, expensive and time-consuming process, especially in oncology.

14 Aug 2018

Pharmaceutical News

AJMC addresses role of community pharmacies in boosting adult vaccination rates

New statewide program in North Dakota aims to stem opioid misuse

ACA's Medicaid expansion associated with increase in prescriptions for opioid use disorder treatment

Ology Bioservices wins $8.4 million worth agreement to manufacture anti-Ebola monoclonal antibody

OHSU professor conducts clinical trial with artificial pancreas using Xeris' liquid glucagon

Biomarker predicts kidney cancer risk years before diagnosis

Hologic’s Cynosure division partners with Porter Instrument to distribute nitrous oxide and oxygen system

Statins may improve conditions of people with rare lung disease

AGA urges policymakers and stakeholders to improve affordability of drugs

FDA grants approval for first generic version of epinephrine auto-injector

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

Sun Pharma receives U.S. FDA approval for CEQUA to treat patients with dry eye disease

Two thyroid medications recalled by FDA

New polyclonal immunotherapy successfully neutralizes Ebola virus

Powerful psychedelic compound can model near-death experiences in the brain

Johns Hopkins expert panel develops first set of operation-specific opioid prescribing guidelines

New digital pharmacy aims to help people living with chronic care conditions

NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease

Using peripheral nerve blocks to treat facial pain may produce long-term pain relief

New strategy accelerates, automates process of prototype molecule optimization

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News